Risk stratification for benign prostatic hyperplasia (BPH) treatment
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2010.10041.x/fullpdf
Reference29 articles.
1. The long-term effect of doxazosin, finasteride, and combination therapy on the progression of benign prostatic hyperplasia;McConnell;N Engl J Med,2003
2. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study;Roehrborn;Eur Urol,2010
3. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006
4. Natural history of benign prostatic enlargement: long-term longitudinal population-based study of prostate volume doubling times;Lieber;BJU Int,2010
5. National Institute for Health and Clinical Excellence Lower urinary tract symptoms. The management of lower urinary tract symptoms in men Clinical Guideline No. 97 http://guidance.nice.org.uk/CG97/NICEGuidance/pdf/English
Cited by 27 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical outcomes of withdrawing one medication from long-term combination therapy comprising α-blocker and 5α-reductase inhibitor for benign prostatic hyperplasia;International Urology and Nephrology;2023-02-10
2. The association between sexual dysfunction and prostate cancer: a systematic review and meta-analysis;The Journal of Sexual Medicine;2023-01-16
3. Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by inducing autophagic apoptosis through endoplasmic reticulum stress;BMC Complementary Medicine and Therapies;2022-05-05
4. Evaluation of a 3-item screening tool to identify men with benign prostatic enlargement/obstruction in a primary care cohort;Minerva Urology and Nephrology;2022-03
5. The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).;Clinical Epidemiology;2021-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3